Loncar Cancer Immunotherapy ETF (CNCR) Charts Showing Bullish OptimismUnion Trade JournalShares of Loncar Cancer Immunotherapy ETF (CNCR) are on watch as the Tenkan Line has moved above the Kijun line, indicating positive momentum for the equity. Lonca… Continue reading
|
上海生科院建立高效谷氨酸棒杆菌CRISPR-Cpf1基因组编辑系统
新浪网 5月4日，《自然-通讯》（Nature Communications）发表了中国科学院上海生命科学研究院植物生理生态研究所合成生物学重点实验室杨晟研究组题为CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicum 的 … |
|
上海生科院建立高效谷氨酸棒杆菌CRISPR-Cpf1基因组编辑系统
新浪网 5月4日，《自然-通讯》（Nature Communications）发表了中国科学院上海生命科学研究院植物生理生态研究所合成生物学重点实验室杨晟研究组题为CRISPR-Cpf1 assisted genome editing of Corynebacterium glutamicum 的 … |
|
Study That Claims CRISPR Causes Unwanted Mutations Is Probably Wrong
ScienceAlert If that was the case, we would have to seriously reconsider the safety of CRISPR, especially when used on humans. But now a paper has been published online claiming it was all a mistake, and the authors of the original study were doing a “disservice to … |
Omaha World-Herald |
Stem cell research is topic of presentation in Lincoln
Omaha World-Herald The University of Nebraska State Museum’s “Sunday with a Scientist” series will explore the basics of stem cell research and regenerative medicine. The July 16 event will start at 1:30 and last until 4:30 p.m. at Morrill Hall, 645 N. 14th St. in Lincoln. |
Genetic Engineering & Biotechnology News |
Human Neural Stem Cell Therapy for Chronic Ischemic Stroke
Genetic Engineering & Biotechnology News Chronic disability after stroke represents a major unmet neurologic need. ReNeuron’s development of a human neural stem cell (hNSC) therapy for chronic disability after stroke is progressing through early clinical studies. A Phase I trial has recently … |